Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

A medication used for the management of hypertension now includes an updated safety label that warns patients of a rare but serious skin condition, according to the Food and Drug Administration (FDA)’s Safety Information and Adverse Event Reporting Program. The new safety label for Inderide (propranolol HCL/hydrochlorothiazide) tablets carries a warning of “erythema multiforme including Stevens Johnson Syndrome (SJS), exfoliative dermatitis, including toxic epidermal necrolysis (TEN)” in the Adverse Reactions section.

Read the rest of this entry »

A drug used to treat acid reflux disease has been linked to a rare but serious skin condition known as Stevens Johnson Syndrome (SJS) and its more severe form, toxic epidermal necrolysis (TEN), according to the Food and Drug Administration (FDA). Dexilant (dexlansoprazole) delayed release capsules now includes a warning of the risk of SJS and TEN in the Adverse Reactions section of its safety label. The updated label states that in post-marketing review, some patients taking Dexilant suffered immune system disorders including anaphylactic shock that required emergency intervention, and SJS and TEN. Some cases were fatal.

Read the rest of this entry »

The commercials for the erectile dysfunction (ED) drug Cialis (tadalafil) say an everyday moment can turn romantic at a moment’s notice. But there’s nothing sexy about the new warning on the drug’s label. According to the February 2010 issue of the Food and Drug Administration (FDA) Drug Safety Labeling report, the drug carries a risk of hypersensitivity reactions, including Stevens Johnson Syndrome (SJS).

Read the rest of this entry »

Tibotec Therapeutics, makers of prescription medication Intelence (etravirine) used to control HIV infection in adults, recently notified health care professionals that the medication has been linked to a rare but life-threatening skin condition known as Stevens Johnson Syndrome, SJS.

Early this year, Intelence was approved by the the Food and Drug Administration (FDA) for use in the treatment of HIV. At that time, data indicated a slight risk of SJS.

SJS, and its most severe form, toxic epidermal necrolysis, TEN, are identified by a rash on the skin that blisters over causing the skin to peel off in sheets. The condition is extremely painful and often requires hospitalization to treat the open wounds on the skin, mouth, eyes and other mucous membranes. Complications include infection, dehydration, vision problems, organ dysfunction and death.

Read the rest of this entry »

Another medication has been added to the list of drugs that have been associated with a rare but life-threatening skin reaction known as Stevens Johnson Syndrome (SJS), and its most severe form, toxic epidermal necrolysis (TEN). Lamictal (Lamotrigine )ODT (orally disintegrating tablets) is a prescription medication for epilepsy and for the maintenance of bipolar disorder. It’s maker, GlaxoSmithKline Pharmaceuticals (GSK) has added the conditions to the PRECAUTIONS and ADVERSE REACTIONS sections of its labeling.

Read the rest of this entry »

The Food and Drug Administration (FDA) along with OSI Pharmaceuticals, Inc. and Genetech has announced that new safety information has been added to the WARNINGS AND PRECAUTIONS sections of the prescribing information for the cancer drug erlotinib, known by the brand name Tarceva. The new labeling warns health care professionals of the risk of sometimes fatal conditions of gastrointestinal perforations, and bullous, blister and exfoliative skin conditions including cases suggestive of Stevens Johnson Syndrome (SJS) and its most serious form, toxic epidermal necrolysis (TEN), during the use of Tarceva.

Read the rest of this entry »

When he was not quite 2 years old, James Lumasag was diagnosed with a rare but life threatening skin condition after receiving a round of antibiotics to treat a cough and fever. The toddler fought for his life in the intensive care unit of a hospital, where he received 22 bags of plasma as his skin peeled away from his body. “His whole body, except his head, looked totally burnt,” his mother Merlyn said. “James suffered too much.”

Read the rest of this entry »

You’ve likely seen the commercials for Detrol. A woman is sitting in her doctor’s office and a woman-shaped figure similar to the ones seen on bathroom doors, is encouraging her to talk to her doctor about her frequent and sudden urges to go to the bathroom. The treatment has helped women find relief from overactive bladder.

Read the rest of this entry »

“This is not right and could have been prevented,” writes someone who commented on Cloanne Andrus Pesquera’s obituary in The Spectrum. Cloanne, 41, died May 30, 2009, after battling a rare but life-threatening condition called Stevens Johnson Syndrome, or SJS. The woman who commented on the story said she had lost her mother to SJS/TEN in 2006. She believes Cloanne’s death, like her mother’s, could have been prevented.

Read the rest of this entry »

A Leeds, England woman is raising money to help a 4-year-old Pakistani boy see again. She could relate.

Patricia Roberts is a survivor of two bouts of Stevens Johnson Syndrome (SJS), a rare but life-threatening condition caused by an adverse reaction to common medication. The condition presents with a rash on the skin that blisters over and causes the skin to peel off in sheets. Victims are susceptible to infection and are often treated in burn units. Blisters also can form in the mouth or on the eyes, which can lead to dehydration or vision problems.

Read the rest of this entry »